Skip Navigation
Search Menu
News and Publications

In This Section      
Print This Page

Current News Releases

Current News Releases

Released: February 16, 2017

The Annual Conference on Retroviruses and Opportunistic Infections

What: The Annual Conference on Retroviruses and Opportunistic Infections

When: Feb. 13–16, 2017

Where: Seattle, Washington, Washington State Convention Center

(705 Pike St., Seattle, WA 98101)

Released: February 14, 2017

Lung cancer specialist Benjamin Levy, M.D., has been named the new clinical director of medical oncology and medical director of thoracic oncology for the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in northwest Washington, D.C.

Released: February 9, 2017

Researchers studying mouse proteins uncover part of “choreography of immunity”

Rearranging the genome is a risky endeavor, and human cells reserve it for special occasions, like making egg and sperm cells. Now, researchers at Johns Hopkins Medicine announce they’ve learned how an enzyme that reshuffles DNA on one of those rare occasions — during the birth of new white blood cells — helps ensure the process doesn’t go haywire. Their results are described online this week in the Proceedings of the National Academy of Sciences.

Released: February 7, 2017

All patients off immunosuppressive drugs more than a year after transplant in small clinical trial

Physicians at the Johns Hopkins Kimmel Cancer Center report they have successfully treated 16 patients with a rare and lethal form of bone marrow failure called severe aplastic anemia using partially matched bone marrow transplants followed by two high doses of a common chemotherapy drug. In a report on the new transplant-chemo regimen, published online Dec. 22, 2016, in Biology of Blood and Marrow Transplantation, the Johns Hopkins team says that more than a year after their transplants, all of the patients have stopped taking immunosuppressive drugs commonly used to treat the disorder and have no evidence of the disease.

Released: February 6, 2017

Johns Hopkins researchers to bring surgical quality improvement initiative to hospitals nationwide

The Johns Hopkins Armstrong Institute for Patient Safety and Quality, in collaboration with the American College of Surgeons, has been awarded a nearly $4 million contract, with the option of $12 million over three years, for a total of about $16 million from the Agency for Healthcare Research and Quality (AHRQ) to improve the outcomes and experiences of surgery patients across the United States. The project, funded and guided by AHRQ, will enable more than 750 hospitals to implement enhanced recovery after surgery (ERAS) protocols, which have been shown to reduce complications, decrease lengths of stay and boost patient experience.

Released: February 2, 2017

Chemical recalibration of brain cells during sleep is crucial for learning, and sleeping pills may sabotage it

Studying mice, scientists at Johns Hopkins have fortified evidence that a key purpose of sleep is to recalibrate the brain cells responsible for learning and memory so the animals can “solidify” lessons learned and use them when they awaken — in the case of nocturnal mice, the next evening.

Released: February 2, 2017

ACO’s efforts to improve patient care and reduce health care costs met with success

The Johns Hopkins Medicine Alliance for Patients (JMAP), the Accountable Care Organization (ACO) of Johns Hopkins Medicine, announces that it has been selected by the Centers for Medicare and Medicaid Services to renew its participation in the Medicare Shared Savings Program for the next three years. The Shared Savings Program offers financial incentives to encourage ACOs to improve coordination, communication and overall care for Medicare fee-for-service beneficiaries while also reducing health care costs.

Released: February 2, 2017

Results reinforce need to provide condoms to drug users, researchers say

Cocaine use has long been tied anecdotally to higher-than-usual rates of impulsive behavior, including risky sex, but the tie-in has been difficult to study with any scientifically controlled rigor.

Released: February 1, 2017

Mouse and human cell studies confirm a common link between proteins and loss of dopamine-making brain cells

Researchers report they have discovered how two problem proteins known to cause Parkinson’s disease are chemically linked, suggesting that someday, both could be neutralized by a single drug designed to target the link. A report on their discovery appears in the Jan. 24 issue of Cell Reports.

Released: January 31, 2017

Reporters, please join Newswise on Thursday, Feb. 2, at 2 p.m. ET for a live event featuring Johns Hopkins’ Vikram Chib and other experts who will scientifically analyze various aspects of this major pop culture event.

Released: January 31, 2017

Our experts, available for interview, can provide some insight on how to successfully start and maintain a healthy lifestyle, including advice on how to kick off the transition to a healthier you, pick the right diet and select strategies that actually help you keep the promises you’ve made.

Released: January 31, 2017

An international research group of 32 experts from nine countries has updated the guidelines for diagnosing the genetic disease cystic fibrosis.

Released: January 31, 2017

Results of a multicenter study of 129 women with advanced breast cancer show that a blood test that spots cancer-linked DNA correctly predicted that most of those patients with higher levels of the tumor markers died significantly earlier than those with lower levels.

Released: January 27, 2017

Study suggests that doctors spend less time with tardy patients in busy clinics

A study examining doctor and patient behavior at three Johns Hopkins Medicine outpatient clinics has found evidence that clinicians spend more face-to-face time with patients when the clinic is on schedule and less when the clinic is running late.

Released: January 27, 2017

The Johns Hopkins University School of Medicine’s Physical Medicine and Rehabilitation Interest Group invites medical students from Maryland and Washington D.C. to the first annual PM&R Expo. This “PM&R 101” event will allow future health care providers to get a taste of the different clinical treatments available within physical medicine and rehabilitation.

Released: January 26, 2017

What: The Society for Maternal-Fetal Medicine’s 37th annual Pregnancy Meeting
When: Jan. 26–28, 2017
Where: Caesars Palace, Las Vegas, Nevada

Released: January 26, 2017

Improper chromosome separation sets the stage for cancer

When a cell is dividing, two identical structures, called centrosomes, move to opposite sides of the cell to help separate its chromosomes into the new cells. More than 100 years ago, scientists observed that cancer cells often have more than two centrosomes, but they couldn’t untangle whether the extra structures were a result of the cancer — or part of its cause. Now, biologists at Johns Hopkins have solved that conundrum, finding that extra centrosomes can single-handedly promote tumor formation in mice.

Released: January 26, 2017

A new survey of 51 youth-serving, nonclinical, community-based organizations in Baltimore, Maryland, found that the majority did not offer HIV testing, nor did they have established links to refer youth to testing. Organizations that did provide HIV tests were more likely to offer general health services and referral services for sexually transmitted infections screening outside of HIV, and had staff members who were more comfortable talking about sexual health issues.

Released: January 26, 2017

Johns Hopkins researchers report that a new peptide holds promise for improving treatment for degenerative retinal diseases, such as age-related macular degeneration, diabetic macular edema and diabetic retinopathy. These vascular diseases often result in central vision loss as blood vessels grow into tissues at the back of the eye, where such growth should not occur.

Released: January 26, 2017

Achievement believed to be a “first”

Generating mature and viable heart muscle cells from human or other animal stem cells has proven difficult for biologists. Now, Johns Hopkins researchers report success in creating them in the laboratory by implanting stem cells taken from a healthy adult or one with a type of heart disease into newborn rat hearts.